<p>As a cholinesterase inhibitor, Rivastigmine may&nbsp;exaggerate the effects of succinylcholine-type muscle relaxants during anaesthesia.&nbsp;Caution is recommended when selecting anaesthetic agents. Possible dose adjustments&nbsp;or temporarily stopping treatment can be considered if needed. In view of its&nbsp;pharmacodynamic effects, rivastigmine should not be given concomitantly with other&nbsp;cholinomimetic substances and might interfere with the activity of anticholinergic&nbsp;medicinal products. No pharmacokinetic interaction was observed between rivastigmine&nbsp;and digoxin, warfarin, diazepam or fluoxetine in studies in healthy volunteers. The increase in prothrombin time induced by warfarin is not affected by administration of&nbsp;rivastigmine. No untoward effects on cardiac conduction were observed following&nbsp;concomitant administration of digoxin and Rivastigmine.</p>